Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Cancer Prev Res (Phila) ; 10(9): 514-524, 2017 Sep.
Article in English | MEDLINE | ID: mdl-28754664

ABSTRACT

Lung cancers are documented to have remarkable intratumoral genetic heterogeneity. However, little is known about the heterogeneity of biophysical properties, such as cell motility, and its relationship to early disease pathogenesis and micrometastatic dissemination. In this study, we identified and selected a subpopulation of highly migratory premalignant airway epithelial cells that were observed to migrate through microscale constrictions at up to 100-fold the rate of the unselected immortalized epithelial cell lines. This enhanced migratory capacity was found to be Rac1-dependent and heritable, as evidenced by maintenance of the phenotype through multiple cell divisions continuing more than 8 weeks after selection. The morphology of this lung epithelial subpopulation was characterized by increased cell protrusion intensity. In a murine model of micrometastatic seeding and pulmonary colonization, the motility-selected premalignant cells exhibit both enhanced survival in short-term assays and enhanced outgrowth of premalignant lesions in longer-term assays, thus overcoming important aspects of "metastatic inefficiency." Overall, our findings indicate that among immortalized premalignant airway epithelial cell lines, subpopulations with heritable motility-related biophysical properties exist, and these may explain micrometastatic seeding occurring early in the pathogenesis of lung cancer. Understanding, targeting, and preventing these critical biophysical traits and their underlying molecular mechanisms may provide a new approach to prevent metastatic behavior. Cancer Prev Res; 10(9); 514-24. ©2017 AACRSee related editorial by Hynds and Janes, p. 491.


Subject(s)
Bronchi/cytology , Cell Movement/genetics , Cell Proliferation/genetics , Epithelial Cells/pathology , Lung Neoplasms/genetics , Animals , Bronchi/pathology , Cell Line, Tumor , Cell Survival/genetics , Epithelial Cells/cytology , Epithelial Cells/metabolism , Gene Expression Profiling , Humans , Lung Neoplasms/pathology , Mice , Mice, Inbred NOD , Specific Pathogen-Free Organisms , Xenograft Model Antitumor Assays , rac1 GTP-Binding Protein/metabolism
2.
Sci Data ; 4: 170020, 2017 03 01.
Article in English | MEDLINE | ID: mdl-28248920

ABSTRACT

We describe a screen for cellular response to drugs that makes use of haploid embryonic stem cells. We generated ten libraries of mutants with piggyBac gene trap transposon integrations, totalling approximately 100,000 mutant clones. Random barcode sequences were inserted into the transposon vector to allow the number of cells bearing each insertion to be measured by amplifying and sequencing the barcodes. These barcodes were associated with their integration sites by inverse PCR. We exposed these libraries to commonly used cancer drugs and profiled changes in barcode abundance by Ion Torrent sequencing in order to identify mutations that conferred sensitivity. Drugs tested included conventional chemotherapeutics as well as targeted inhibitors of topoisomerases, poly(ADP-ribose) polymerase (PARP), Hsp90 and WEE1.


Subject(s)
DNA Transposable Elements , Mouse Embryonic Stem Cells , Neoplasms , Animals , Antineoplastic Agents/pharmacology , Genome-Wide Association Study , Haploidy , Mice , Neoplasms/drug therapy , Neoplasms/genetics
3.
Crit Rev Oncog ; 20(5-6): 449-73, 2015.
Article in English | MEDLINE | ID: mdl-27279241

ABSTRACT

Metastatic disease is responsible for 90% of death from solid tumors. However, only a minority of metastasis-specific targets has been exploited therapeutically, and effective prevention and suppression of metastatic disease is still an elusive goal. In this review, we will first summarize the current state of knowledge about the molecular features of the disease, with particular focus on steps and targets potentially amenable to therapeutic intervention. We will then discuss the reasons underlying the paucity of metastatic drugs in the current oncological arsenal and potential ways to overcome this therapeutic gap. We reason that the discovery of novel promising targets, an increased understanding of the molecular features of the disease, the effect of disruptive technologies, and a shift in the current preclinical and clinical settings have the potential to create more successful drug development endeavors.


Subject(s)
Antineoplastic Agents/therapeutic use , Neoplasm Metastasis/prevention & control , Animals , Antineoplastic Agents/pharmacology , Drug Discovery , Humans
4.
Ital J Biochem ; 56(2): 91-102, 2007 Jun.
Article in English | MEDLINE | ID: mdl-17722649

ABSTRACT

Human DNA Topoisomerase I is a 765aa monomeric enzyme composed of four domains: the N-terminal domain, highly charged and responsible for several protein-protein interactions, the core domain that embraces the DNA during catalysis, the highly charged linker domain and the C-teminal domain containing the active site. The enzyme promotes the relaxation of supercoiled DNA by nicking and rejoining one of the strands of the DNA. Its activity is critical for many biological processes including DNA replication, transcription, and recombination. The aim of this review is to analyze the enzyme activity in terms of structure-function relationship.


Subject(s)
DNA Replication/physiology , DNA Topoisomerases, Type I/metabolism , DNA, Superhelical/metabolism , Recombination, Genetic/physiology , Transcription, Genetic/physiology , Catalysis , DNA Topoisomerases, Type I/chemistry , DNA, Superhelical/chemistry , Humans , Protein Structure, Tertiary/physiology , Structure-Activity Relationship
SELECTION OF CITATIONS
SEARCH DETAIL
...